On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Praveen Thokala

ResearcherPublications, citations & collaboration network

Praveen Thokala is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Praveen Thokala have?

ScholarIQindexed works

Praveen Thokala has 282 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Praveen Thokala have?

ScholarIQcitation count

Praveen Thokala has 5,715 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Praveen Thokala?

ScholarIQh-index

Praveen Thokala has an h-index of 36 in OpenAlex.

What is the i10-index of Praveen Thokala?

ScholarIQi10-index

Praveen Thokala has an i10-index of 90 in OpenAlex.

What is the ORCID of Praveen Thokala?

ScholarIQorcid

The ORCID for Praveen Thokala is on the source record.

What is the OpenAlex record for Praveen Thokala?

ScholarIQopenalex

The OpenAlex for Praveen Thokala is on the source record.

What are the most-cited papers on Praveen Thokala?

ScholarIQmost cited works
Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
Praveen Thokala, Nancy Devlin, Kevin Marsh, Rob Baltussen, Meindert Boysen, Zoltán Kaló, Thomas Longrenn, Filip Mussen, Stuart Peacock, John B. Watkins, Maarten J. IJzerman
Value in Health. 2016738 CitationsOPEN ACCESS
Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
Kevin Marsh, Maarten J. IJzerman, Praveen Thokala, Rob Baltussen, Meindert Boysen, Zoltán Kaló, Thomas Lönngren, Filip Mussen, Stuart Peacock, John B. Watkins, Nancy Devlin
Value in Health. 2016476 CitationsOPEN ACCESS
Multiple Criteria Decision Analysis for Health Technology Assessment
Praveen Thokala, Alejandra Duenas
Value in Health. 2012329 CitationsOPEN ACCESS
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Mark Bond, G Rogers, J Peters, Rodney P. Anderson, Martin Hoyle, A Miners, T Moxham, Sarah Davis, Praveen Thokala, Allan Wailoo, Mona Jeffreys, Christopher Hyde
Health Technology Assessment. 2012307 CitationsOPEN ACCESS
Cost-Effectiveness Thresholds: the Past, the Present and the Future
Praveen Thokala, Jessica Ochalek, Ashley A. Leech, Thaison Tong
PharmacoEconomics. 2018201 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial